Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
Top Cited Papers
- 24 April 2004
- journal article
- research article
- Published by Elsevier
- Vol. 363 (9418) , 1346-1353
- https://doi.org/10.1016/s0140-6736(04)16044-3
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Insulin, Insulin-Like Growth Factor-I (IGF-I), IGF Binding Proteins, Their Biologic Interactions, and Colorectal CancerJNCI Journal of the National Cancer Institute, 2002
- Statistical methods for assessing the influence of study characteristics on treatment effects in ‘meta‐epidemiological’ researchStatistics in Medicine, 2002
- Insulin-Like Growth Factor I, IGF-Binding Protein 3, and Lung Cancer Risk in a Prospective Study of Men in ChinaJNCI Journal of the National Cancer Institute, 2002
- A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in womenInternational Journal of Cancer, 2001
- High-risk colorectal adenomas and serum insulin-like growth factorsBritish Journal of Surgery, 2001
- Serum insulin-like growth factor-I and breast cancerInternational Journal of Cancer, 2000
- Role of the Insulin-Like Growth Factor Family in Cancer Development and ProgressionJNCI Journal of the National Cancer Institute, 2000
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- Free insulin‐like growth factors (IGF‐I and IGF‐II) in human serumFEBS Letters, 1994
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986